To serve families in need and effectively reduce the risk of respiratory infectious diseases in autumn and winter, Shenzhen Xinfeng and Mujia Hospital is open on weekends RSV The medication service for Nixavir monoclonal antibody can be reserved in advance~

 

Respiratory syncytial virus is an extremely common and highly contagious respiratory virus that poses a serious threat to the health of babies. face, confront RSV Parents should not take the potential threat lightly and should remain vigilant at all times, taking comprehensive and effective preventive measures for their babies in advance.

 

At the end of September last year, the world's first monoclonal antibody for respiratory syncytial virus prevention targeting all infants (0-1 years old), Nisevermab, was approved for sale in China, which can help children prevent respiratory syncytial virus RSV Causing lower respiratory tract infections.

 

Q： Is Nixavir monoclonal antibody a vaccine?

A： No, unlike the active immune mechanism of vaccines that initiate the production of antibodies in the human body, Nixivizumab itself is a preventive antibody that is injected directly into the body RSV The combination of viruses provides passive immunity, providing timely, rapid, and direct protection for babies, and vaccines are not better than vaccines.

 

Q： At what age is Nixivir monoclonal antibody suitable for children?

A： Nixivir monoclonal antibody is suitable for newborns and infants aged 0-12 months, including premature infants and infants with underlying diseases.

 

Q： Can a baby over 1 year old still be vaccinated with Nixivir monoclonal antibody?

A： currently RSV The record of the instruction manual has been approved, according to FDA According to the standard, babies under 24 months of age must meet the criteria after evaluation by a pediatrician. After communication with the patient's family, the pediatrician must sign an informed consent form beyond the instructions before using 200mg (100mg for two injections).

 

 

Q： How many doses are required for routine administration of Nixivir monoclonal antibody?

A： Routine vaccination with one shot, subject to the doctor's evaluation.

 

Q： How long can the protective effect of a single dose of Nixivir monoclonal antibody last? How long does it take to take effect?

A： Nisevermab provides immediate protection upon injection, and the clearance rate of drug-resistant antibodies against Nisevermab is up to 5 months. It is currently recognized that the best protection period is at least 5 months, which can almost cover the entire body RSV Pop season.

 

Q： What is the injection dose of Nixivir monoclonal antibody?

A： According to the drug instructions, for those who are about to enter or born in the first place RSV Newborns or infants under 1 year old during the infection season:

Weight<5 kg The recommended dosage for infants is a single intramuscular injection of 50 mg（ Our price is 1869 per unit;
 

 

Weight ≥ 5 kg The recommended dosage for infants is 100 per intramuscular injection mg（ Our price is 3177 per unit.
 

 

Q：RSV Is the infection severe? Do we really need to hit the child?

A： All infants are at risk of respiratory syncytial virus infection. RSV It is the primary pathogen detected in hospitalized infants and young children due to lower respiratory tract infections, mainly pneumonia and bronchiolitis. Under 1 year old RSV Infants with severe infections have a risk of recurrent wheezing that increases by more than 2 times, an asthma risk that increases by about 3 times, and impaired lung function that may persist for several years.

Nixavir monoclonal antibody is currently the first approved response in China to protect the vast infant population RSV Monoclonal antibodies against infection.

 

Q： Can the baby still be vaccinated if they have already been infected with the syncytial virus?

A： The consensus in China has not provided a clear answer, and it is necessary to conduct specific analysis with pediatricians based on the baby's condition.

 

Fortunately, the mechanism of action of Nisevermab is to directly target RSV The preventive effect of the virus will not be affected by the antibodies already present in the child's body after infection.

 

Whether to choose to inject Nixivir monoclonal antibody into children after infection should mainly be based on the evaluation of the risk of reinfection.

 

For example, for infants under 6 months old, or those with increased severity of congenital heart disease, chronic lung disease, immune dysfunction, etc RSV Children at risk of infection, if RSV If the child has already been infected once during the early stages of the epidemic season, administering an injection in the early stages of the epidemic season will provide strong protection for the child during the remaining epidemic season.

 

Q： What are the adverse reactions of injection of Nixivir monoclonal antibody?

A： The incidence of adverse reactions to Nixavir monoclonal antibody is low, commonly including rash, fever, redness and swelling at the injection site, etc. It usually recovers on its own within 1-2 days after occurrence, and observation for 30 minutes is required after injection completion.

 

Q： Can Nixavir monoclonal antibody be administered simultaneously with other vaccines?

A： Sure, Nixivizumab is a monoclonal antibody that targets RSV In clinical trials, the safety and prototype characteristics of the virus when used in combination with conventional pediatric vaccines are similar to those of pediatric vaccines used alone. But it is recommended to choose to inject at different locations when receiving other vaccines at the same time.

 

Q： Is it still possible to inject Nixivir monoclonal antibody when babies are prone to allergies?

A： Those who have any serious allergic reactions to the ingredients of the drug should not be vaccinated. The ingredients are as follows:

Active ingredient: Nixivir monoclonal antibody.

Accessories: Histidine, Histidine Hydrochloride, Arginine Hydrochloride, Sucrose, Polysorbate 80, Injection Water.

All others can be vaccinated after evaluation by a doctor.

 

Q： Where is the injection site for Nifedipib monoclonal antibody?

A： Nixivir monoclonal antibody is only used for intramuscular injection, and it is chosen to be injected on the anterior outer thigh because there is a risk of damaging the sciatic nerve. Therefore, the gluteal muscle is not selected as a routine injection site.

 

 

Q： What should I pay attention to at home after injecting Nixivir monoclonal antibody?

A：> Observe whether the child has any abnormal reactions.

>Continue to take preventive measures, such as washing hands frequently and avoiding contact with sick people.

>Regular health check ups are conducted to ensure the overall health of the child.

 

Q： Do both children at home need to be vaccinated with Nifedipib?

A： It is recommended that babies who meet the requirements can be vaccinated. The infectivity of syncytial viruses is very strong, and they are very easy to "infect each other". If there are two treasures at home, it is possible that Da Bao has not yet shown any symptoms, and Er Bao has already been infected. In addition, elderly people are also susceptible to syncytial virus, and getting vaccinated can prevent them from getting infected while taking care of their children.

 

Q： How much does it cost to get vaccinated with Nixivir monoclonal antibody at Shenzhen Xinfeng and Mujia Hospital? How to make an appointment?

A： As the first hospital in Shenzhen to introduce this drug, our hospital offers package prices of 2220 yuan (<5kg) or 3528 yuan (≥ 5kg), including consultation fees.